Azithromycin plus chloroquine + sulfadoxine-pyrimethamine

Phase 3Terminated

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Intermittent Preventive Treatment In Pregnancy (IPTp)

Conditions

Intermittent Preventive Treatment In Pregnancy (IPTp)

Trial Timeline

Oct 1, 2010 → Nov 1, 2013

NCT ID

NCT01103063

About Azithromycin plus chloroquine + sulfadoxine-pyrimethamine

Azithromycin plus chloroquine + sulfadoxine-pyrimethamine is a phase 3 stage product being developed by Pfizer for Intermittent Preventive Treatment In Pregnancy (IPTp). The current trial status is terminated. This product is registered under clinical trial identifier NCT01103063. Target conditions include Intermittent Preventive Treatment In Pregnancy (IPTp).

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01103063	Phase 3	Terminated	Oct 1, 2010	Nov 1, 2013	Intermittent Preventive Treatment In Pregnancy (IPTp)

Competing Products

12 competing products in Intermittent Preventive Treatment In Pregnancy (IPTp)

See all competitors

Product	Company	Stage	Hype Score
Fluticasone propionate (Flovent Diskus) 250 mcg + budesonide 400 mcg	AstraZeneca	Approved	85
LLG783 + Placebo	Novartis	Phase 2	52
ataciguat (HMR1766) + placebo + cilostazol	Sanofi	Phase 2	51
Ad2/HIF-1α/VP16 + Ad2/HIF-1α/VP16 + Ad2/HIF-1α/VP16	Sanofi	Phase 2	51
SL650472, Clopidogrel	Sanofi	Phase 2	51
Givosiran	Alnylam Pharmaceuticals	Phase 1/2	38
Givosiran + 5-probe cocktail	Alnylam Pharmaceuticals	Phase 1	30
givosiran (ALN-AS1) + Sterile Normal Saline (0.9% NaCl)	Alnylam Pharmaceuticals	Phase 1	30
Sapropterin Dihydrochloride	BioMarin Pharmaceutical	Phase 2	49
Tetrahydrobiopterin 10 mg/kg + Tetrahydrobiopterin 20 mg/kg + L-Ascorbate + L-Arginine	BioMarin Pharmaceutical	Phase 1	30
Placebo + 375 mg CK-2017357 + 500 mg CK-2017357	Cytokinetics	Phase 2	49
Pimavanserin 34 mg + Placebo	Acadia Pharmaceuticals	Phase 2	47

Other Products from Pfizer